Developer and manufacturer of biological chemicals intended to use in various therapeutic areas including oncology and antiviral and respiratory. The company relies on core technologies such as biological enzyme catalysis and continuous microfluidic reaction and is dedicated to building an internationally leading and customer-preferred biomedical contract research organization (CRO)/ contract development and manufacturing company (CDMO) services platform, providing pharmaceutical companies with a contract research organization (CRO)/ contract development and manufacturing company (CDMO) services.